Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
Recently, the Biosimilars Forum submitted comments on the Centers for Medicare & Medicaid Services' (CMS) proposed Medicare Physician Fee Schedule...
The Biosimilars Forum—the nonprofit organization solely dedicated to expanding patient access to biosimilars in the United States—today issued the...
The Biosimilars Forum – the nonprofit organization solely dedicated to expanding patient access to biosimilars in the United States – issued the...
The Biosimilars Forum – the nonprofit organization solely dedicated to expanding patient access to biosimilars in the United States – today announced ...
The Biosimilars Forum today issued comments in response to a proposed rule released by the Food and Drug Administration (FDA) to designate official...
The Biosimilars Forum today expressed support for Senators Pat Roberts (R-KS) and Tom Carper (D-DE) as well as 18 additional Senators for their...
A coalition of 11 leading companies involved in the development and manufacturing of biopharmaceuticals and "biosimilar" medicines today announced...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.